Literature DB >> 12169678

A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma.

Taisuke Hosaka1, Yasuaki Nakashima, Katsuyuki Kusuzaki, Hiroaki Murata, Tomitaka Nakayama, Takeharu Nakamata, Tomoki Aoyama, Takeshi Okamoto, Kohichi Nishijo, Nobuhito Araki, Tadao Tsuboyama, Takashi Nakamura, Junya Toguchida.   

Abstract

Fusion genes consisting of TLS/FUS and CHOP or EWS and CHOP are characteristic markers for myxoid/round cell liposarcomas (MLS/RCLS). Several different structures of the fusion genes were reported in the case of the TLS/FUS-CHOP form, whereas only one type of structure has so far been found for the EWS-CHOP form, which consisted of exons 1 to 7 of the EWS and exons 2 to 4 of the CHOP gene. Here we describe a novel type of EWS-CHOP fusion gene in two cases of MLS/RCLS, which were found in a consecutive analysis of 21 cases. This fusion gene consisted of exons 1 to 10 of the EWS and exons 2 to 4 of the CHOP gene. The two cases with this fusion gene shared several clinical features, such as a large tumor mass, rapid and invasive growth, and local recurrence within 12 months after surgical resection. Histopathological findings also showed common features characterized by the diffuse proliferation of small spindle cells with a primitive mesenchymal appearance. The association of these clinical and histopathological features suggests a distinct biological property for this rare type of fusion product.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169678      PMCID: PMC1906982          DOI: 10.1016/S1525-1578(10)60698-8

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  30 in total

1.  EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

Authors:  E de Alava; A Kawai; J H Healey; I Fligman; P A Meyers; A G Huvos; W L Gerald; S C Jhanwar; P Argani; C R Antonescu; F J Pardo-Mindan; J Ginsberg; R Womer; E R Lawlor; J Wunder; I Andrulis; P H Sorensen; F G Barr; M Ladanyi
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

2.  Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features.

Authors:  P Dal Cin; R Sciot; I Panagopoulos; P Aman; I Samson; N Mandahl; F Mitelman; H Van den Berghe; C D Fletcher
Journal:  J Pathol       Date:  1997-08       Impact factor: 7.996

Review 3.  TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation.

Authors:  D Ron
Journal:  Curr Top Microbiol Immunol       Date:  1997       Impact factor: 4.291

4.  Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.

Authors:  K M Kelly; R B Womer; P H Sorensen; Q B Xiong; F G Barr
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

5.  Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.

Authors:  P P Lin; R I Brody; A C Hamelin; J E Bradner; J H Healey; M Ladanyi
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

6.  Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma.

Authors:  I Panagopoulos; P Aman; F Mertens; N Mandahl; A Rydholm; H F Bauer; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1996-10       Impact factor: 5.006

7.  SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.

Authors:  A Kawai; J Woodruff; J H Healey; M F Brennan; C R Antonescu; M Ladanyi
Journal:  N Engl J Med       Date:  1998-01-15       Impact factor: 91.245

8.  Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.

Authors:  H Kanoe; T Nakayama; T Hosaka; H Murakami; H Yamamoto; Y Nakashima; T Tsuboyama; T Nakamura; D Ron; M S Sasaki; J Toguchida
Journal:  Oncogene       Date:  1999-01-21       Impact factor: 9.867

9.  Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy.

Authors:  Y Kaneko; K Yoshida; M Handa; Y Toyoda; H Nishihira; Y Tanaka; Y Sasaki; S Ishida; F Higashino; K Fujinaga
Journal:  Genes Chromosomes Cancer       Date:  1996-02       Impact factor: 5.006

10.  Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.

Authors:  M Hisaoka; S Tsuji; Y Morimitsu; H Hashimoto; S Shimajiri; S Komiya; M Ushijima
Journal:  Diagn Mol Pathol       Date:  1998-04
View more
  10 in total

1.  Myxoid liposarcoma with cartilaginous differentiation showing DDIT3 rearrangement.

Authors:  Kayo Suzuki; Taketoshi Yasuda; Kenta Watanabe; Takeshi Hori; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

2.  Variation in myxoid liposarcoma: Clinicopathological examination of four cases with detectable TLS-CHOP or EWS-CHOP fusion transcripts whose histopathological diagnosis was other than myxoid liposarcoma.

Authors:  Kayo Suzuki; Yoshito Matsui; Nobuyuki Hashimoto; Norifumi Naka; Nobuhito Araki; Tomoatsu Kimura; Hideki Yoshikawa; Takafumi Ueda
Journal:  Oncol Lett       Date:  2011-11-15       Impact factor: 2.967

3.  Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.

Authors:  Ronald S A de Vreeze; Daphne de Jong; Petra M Nederlof; Aafke Ariaens; Ivon H G Tielen; Luc Frenken; Rick L Haas; Frits van Coevorden
Journal:  Ann Surg Oncol       Date:  2010-03       Impact factor: 5.344

4.  Multifocal myxoid liposarcoma--metastasis or second primary tumor?: a molecular biological analysis.

Authors:  Ronald de Vreeze; Daphne de Jong; Petra Nederlof; Henrique J Ruijter; Lucie Boerrigter; Rick Haas; Frits van Coevorden
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

5.  Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy.

Authors:  Wei-Lien Wang; Daniela Katz; Dejka M Araujo; Vinod Ravi; Joseph A Ludwig; Jonathan C Trent; Shreyaskumar R Patel; Patrick P Lin; Ashleigh Guadagnolo; Dolores Lòpez-Terrada; Angelo Paola Dei Tos; Valerie O Lewis; Dina Lev; Raphael E Pollock; Gunar K Zagars; Robert S Benjamin; John E Madewell; Alexander J Lazar
Journal:  Clin Sarcoma Res       Date:  2012-12-29

6.  The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities.

Authors:  Jonathan Noujaim; Robin L Jones; John Swansbury; David Gonzalez; Charlotte Benson; Ian Judson; Cyril Fisher; Khin Thway
Journal:  Br J Cancer       Date:  2017-01-31       Impact factor: 7.640

7.  CHOP 5'UTR-c.279T>C and +nt30C>T variants are not associated with overweight condition or with tumors/cancer in Italians - a case-control study.

Authors:  Ramachandran Meenakshisundaram; Nunzia Piumelli; Laura Pierpaoli; Claudia Gragnoli
Journal:  J Exp Clin Cancer Res       Date:  2009-06-26

Review 8.  Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors.

Authors:  Monica Cantile; Laura Marra; Renato Franco; Paolo Ascierto; Giuseppina Liguori; Annarosaria De Chiara; Gerardo Botti
Journal:  Med Oncol       Date:  2013-01-18       Impact factor: 3.064

9.  Cytogenetics and molecular genetics of myxoid soft-tissue sarcomas.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masatoshi Naito
Journal:  Genet Res Int       Date:  2011-07-28

10.  Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin.

Authors:  Hannah C Beird; Chia-Chin Wu; Davis R Ingram; Wei-Lien Wang; Asrar Alimohamed; Curtis Gumbs; Latasha Little; Xingzhi Song; Barry W Feig; Christina L Roland; Jianhua Zhang; Robert S Benjamin; Patrick Hwu; Alexander J Lazar; P Andrew Futreal; Neeta Somaiah
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.